• 1
    Donegan WL. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin. 1997; 47: 2851.
  • 2
    Heimann R, Hellman S. Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol. 2000; 18: 591599.
  • 3
    Fisher ER, Redmond C, Fisher B. Prognostic factors in NSABP studies of women with node-negative breast cancer. National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst Monogr. 1992; 11: 151158.
  • 4
    Fisher B, Digman J, Tan-Chu E, et al. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst. 2001; 93: 112120.
  • 5
    Andrulis IL, Bull SB, Blackstein ME, et al. Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. J Clin Oncol. 1998; 16: 13401349.
  • 6
    Thor AD, Berry DA, Budman DR, et al. ErbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst. 1998; 90: 13461360.
  • 7
    Swanson GM, Lin CS. Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. J Natl Cancer Inst Monogr. 1994; 16: 6977.
  • 8
    Edwards MJ, Gamel JW, Vaughan WP, Wrightson WR. Infiltrating ductal carcinoma of the breast: the survival impact of race. J Clin Oncol. 1998; 16: 26932699.
  • 9
    RiesLA, EisnerMP, KosaryCL, et al., editors. SEER Cancer Statistics Review, 1973-1997. Bethesda, MD: National Cancer Institute, 2000.
  • 10
    Lee CG, McCormick B, Mazumdar M, Vetto J, Borgen PI. Infiltrating breast carcinoma in patients aged 30 years and younger: long-term outcome for life, relapse, and second primary tumors. Int J Radiat Oncol Biol Phys. 1992; 23: 969975.
  • 11
    Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996; 77: 97103.
  • 12
    Albain KS, Allred DC, Clark GM. Breast cancer outcome and predictors of outcome: are there age differentials? J Natl Cancer Inst Monogr. 1994; 16: 3542.
  • 13
    Newman LA, Alfonso AE. Age-related differences in breast cancer stage at diagnosis between black and white patients in an urban community hospital. Ann Surg Oncol. 1997; 4: 655662.
  • 14
    Marbella AM, Layde PM. Racial trends in age-specific breast cancer mortality rates in US women. Am J Public Health. 2001; 91: 118121.
  • 15
    Newman LA, Carolin K, Simon M, et al. Impact of breast cancer on African American women: the Detroit experience. Cancer. 2001; 91: 18341843.
  • 16
    Cox DR. Regression models and life-tables. JR Statistical Society. 1972; B4: 187220.
  • 17
    SteeleGD OsteenRT, WinchesterDP, et al, editors. National Cancer Database Annual Review of Patient Care. Atlanta, GA: American Cancer Society 1994.
  • 18
    El-Tamer MB, Homel P, Wait RB. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999; 189: 4145.
  • 19
    Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994; 86: 705712.
  • 20
    Olopade OI, Weber BL. Breast cancer genetics: toward molecular characterization of individuals at increased risk for breast cancer. Part I. In: DeVitaT, HellmanS, RosenbergSA, editors. Cancer Principles and Practice of Oncology Updates. 1998; 12: 112.
  • 21
    Mohla S, Sampson CC, Khan T, et al. Estrogen and progesterone receptors in breast cancer in black Americans: correlation of receptor data with tumor differentiation. Cancer. 1982; 50: 552559.
  • 22
    Simon MS, Severson RK. Racial differences in breast cancer survival: The interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol. 1997; 176: S233S239.
  • 23
    Gordon N, Crowe J, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol. 1992; 135: 609618.
  • 24
    Freeman HP, Wasfie TJ. Cancer of the breast in poor black women. Cancer. 1989; 63: 25622569.
  • 25
    Kovi J, Mohla S, Norris HJ, Sampson CC, Heshmat MY. Breast lesions in black women. Pathol Annu. 1989; 24: 199218.
  • 26
    Natarajan N, Nemoto T, Mettlin C, Murphy GP. Race-related differences in breast cancer patients. Cancer. 1985; 56: 17041709.
  • 27
    Johannsson OT, Idvall I, Anderson C, et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer. 1997; 33: 362371.
  • 28
    Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet. 1997; 349: 15051510.
  • 29
    Robson M, Rajan P, Rosen PP, et al. BRCA-associated breast cancer: absence of a characteristic immunophenotype. Cancer Res. 1998; 58: 18391842.
  • 30
    Verhoog LC, Brekelmans CT, Seynaeve C, et al. Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1. Lancet. 1998; 351: 316321.
  • 31
    Eisinger F, Jacquemier J, Charpin C, et al. Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res. 1998; 58: 15881592.
  • 32
    Armes JE, Trute L, White D, et al. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res. 1999; 59: 20112017.
  • 33
    Gao Q, Neuhausen S, Cummings S, et al. Recurrent germ-line mutations in extended African American families with early-onset breast cancer. Am J Hum Genet. 1997; 60: 12331236.
  • 34
    Pathak DR, Osuch JR, He J. Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer. 2000; 88: 12301238.
  • 35
    Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947954.
  • 36
    Heimann R, Fergusan D, Powers C, Suri D, Weichselbaum RR, Hellman S. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997; 15: 23292337.
  • 37
    Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998; 82: 13101318.
  • 38
    Yood MU, Cole CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999; 91: 14871491.